Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:4XM's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.985 * Ranked among companies with meaningful EV-to-EBIT only.
Lords and Company Worldwide Holdings (FRA:4XM) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Lords and Company Worldwide Holdings's Enterprise Value for the quarter that ended in Aug. 2023 was €0.02 Mil.
Lords and Company Worldwide Holdings's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lords and Company Worldwide Holdings EV-to-EBIT Related Terms
Lords and Company Worldwide Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lords and Company Worldwide Holdings EV-to-EBIT Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Lords and Company Worldwide Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lords and Company Worldwide Holdings EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lords and Company Worldwide Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Lords and Company Worldwide Holdings's EV-to-EBIT falls into.
Lords and Company Worldwide Holdings's current Enterprise Value is €0.74 Mil.
Lords and Company Worldwide Holdings's EBIT for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lords and Company Worldwide Holdings (FRA:4XM) has a EV-to-EBIT of -0.47 as of Sep. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lords and Company Worldwide Holdings and its competitors.
Is Lords and Company Worldwide Holdings' EV-to-EBIT too high?
Lords and Company Worldwide Holdings' current EV-to-EBIT is -0.47.
How does Lords and Company Worldwide Holdings' EV-to-EBIT compare to ZTS and CTLT?
Lords and Company Worldwide Holdings' EV-to-EBIT of -0.47 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.99, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lords and Company Worldwide Holdings and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lords and Company Worldwide Holdings's current EV-to-EBIT is -0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lords and Company Worldwide Holdings stock overvalued right now?
Lords and Company Worldwide Holdings (FRA:4XM) has a current EV-to-EBIT of -0.47. The current EV-to-EBIT is -0.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Lords and Company Worldwide Holdings (FRA:4XM), the current EV-to-EBIT is -0.47 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lords and Company Worldwide Holdings Corp develops, produces, and markets lifestyle apparel and natural health products through its e-Commerce platform to retail, B2B and B2C, consumers in North America and Europe utilizing its proprietary direct-to-consumer platform. Through continuous strategic white labelling, Lords has a footprint in the nutraceutical product markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4XM has been successfully added to your 
